These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 7753969

  • 1. Novel alkoxy-oxazolyl-tetrahydropyridine muscarinic cholinergic receptor antagonists.
    Shannon HE, Bymaster FP, Hendrix JC, Quimby SJ, Mitch CH.
    Psychopharmacology (Berl); 1995 Jan; 117(2):208-15. PubMed ID: 7753969
    [Abstract] [Full Text] [Related]

  • 2. Alterations in behavioral responses to a cholinergic agonist in post-pubertal rats with neonatal ventral hippocampal lesions: relationship to changes in muscarinic receptor levels.
    Laplante F, Nakagawasai O, Srivastava LK, Quirion R.
    Neuropsychopharmacology; 2005 Jun; 30(6):1076-87. PubMed ID: 15637638
    [Abstract] [Full Text] [Related]

  • 3. The pharmacological assessment of RS 86 (2-ethyl-8-methyl-2,8-diazaspiro-[4,5]-decan-1,3-dion hydrobromide). A potent, specific muscarinic acetylcholine receptor agonist.
    Palacios JM, Bolliger G, Closse A, Enz A, Gmelin G, Malanowski J.
    Eur J Pharmacol; 1986 Jun 05; 125(1):45-62. PubMed ID: 3732391
    [Abstract] [Full Text] [Related]

  • 4. In vivo muscarinic cholinergic mediated effects of Lu 25-109, a M1 agonist and M2/M3 antagonist in vitro.
    Sánchez C, Arnt J, Didriksen M, Dragsted N, Moltzen Lenz S, Matz J.
    Psychopharmacology (Berl); 1998 Jun 05; 137(3):233-40. PubMed ID: 9683000
    [Abstract] [Full Text] [Related]

  • 5. Comparative behavioral and neurochemical activities of cholinergic antagonists in rats.
    Bymaster FP, Heath I, Hendrix JC, Shannon HE.
    J Pharmacol Exp Ther; 1993 Oct 05; 267(1):16-24. PubMed ID: 7901390
    [Abstract] [Full Text] [Related]

  • 6. Synthesis and structure-activity studies of a series of 1-oxa-2,8-diazaspiro[4.5]decan-3-ones and related compounds as M1 muscarinic agonists.
    Tsukamoto S, Nagaoka H, Igarashi S, Wanibuchi F, Hidaka K, Tamura T.
    Chem Pharm Bull (Tokyo); 1995 Sep 05; 43(9):1523-9. PubMed ID: 7586076
    [Abstract] [Full Text] [Related]

  • 7. Genetic influences on tolerance development with chronic oxotremorine infusion.
    Marks MJ, Romm E, Collins AC.
    Pharmacol Biochem Behav; 1987 Aug 05; 27(4):723-32. PubMed ID: 3659096
    [Abstract] [Full Text] [Related]

  • 8. Postsynaptic integration of cholinergic and dopaminergic signals on medium-sized GABAergic projection neurons in the neostriatum.
    Harsing LG, Zigmond MJ.
    Brain Res Bull; 1998 Apr 05; 45(6):607-13. PubMed ID: 9566505
    [Abstract] [Full Text] [Related]

  • 9. Blockade of hippocampal M1 muscarinic receptors impairs working memory performance of rats.
    Ohno M, Yamamoto T, Watanabe S.
    Brain Res; 1994 Jul 11; 650(2):260-6. PubMed ID: 7953691
    [Abstract] [Full Text] [Related]

  • 10. The involvement of muscarinic receptor subtypes in the mediation of hypothermia, tremor, and salivation in male mice.
    Sánchez C, Lembøl HL.
    Pharmacol Toxicol; 1994 Jan 11; 74(1):35-9. PubMed ID: 8159635
    [Abstract] [Full Text] [Related]

  • 11. Gallamine binding to muscarinic M1 and M2 receptors, studied by inhibition of [3H]pirenzepine and [3H]quinuclidinylbenzilate binding to rat brain membranes.
    Burke RE.
    Mol Pharmacol; 1986 Jul 11; 30(1):58-68. PubMed ID: 3755217
    [Abstract] [Full Text] [Related]

  • 12. Synthesis and muscarinic activities of 3-(pyrazolyl)-1,2,5,6-tetrahydropyridine derivatives.
    Plate R, Plaum MJ, de Boer T, Andrews JS, Rae DR, Gibson S.
    Bioorg Med Chem; 1996 Feb 11; 4(2):227-37. PubMed ID: 8814880
    [Abstract] [Full Text] [Related]

  • 13. In vivo antimuscarinic actions of the third generation antihistaminergic agent, desloratadine.
    Howell G, West L, Jenkins C, Lineberry B, Yokum D, Rockhold R.
    BMC Pharmacol; 2005 Aug 18; 5():13. PubMed ID: 16109168
    [Abstract] [Full Text] [Related]

  • 14. Discriminative stimulus properties of the muscarinic receptor agonists Lu 26-046 and O-Me-THPO in rats: evidence for involvement of different muscarinic receptor subtypes.
    Arnt J, Lembøl HL, Meier E, Pedersen H.
    Eur J Pharmacol; 1992 Jul 21; 218(1):159-69. PubMed ID: 1397027
    [Abstract] [Full Text] [Related]

  • 15. Xanomeline: a novel muscarinic receptor agonist with functional selectivity for M1 receptors.
    Shannon HE, Bymaster FP, Calligaro DO, Greenwood B, Mitch CH, Sawyer BD, Ward JS, Wong DT, Olesen PH, Sheardown MJ, Swedberg MD, Suzdak PD, Sauerberg P.
    J Pharmacol Exp Ther; 1994 Apr 21; 269(1):271-81. PubMed ID: 7909557
    [Abstract] [Full Text] [Related]

  • 16. Antagonism of nucleus accumbens M(2) muscarinic receptors disrupts operant responding for sucrose under a progressive ratio reinforcement schedule.
    Cousens GA, Beckley JT.
    Behav Brain Res; 2007 Jul 19; 181(1):127-35. PubMed ID: 17499370
    [Abstract] [Full Text] [Related]

  • 17. Synthesis and biological evaluation of phenylacetyl derivatives having low central nervous system permeability as potent and selective M2 muscarinic receptor antagonists.
    Watanabe T, Kakefuda A, Tanaka A, Takizawa K, Hirano S, Shibata H, Yamagiwa Y, Yanagisawa I.
    Chem Pharm Bull (Tokyo); 1998 Jan 19; 46(1):53-68. PubMed ID: 9468637
    [Abstract] [Full Text] [Related]

  • 18. BM-5, a centrally active partial muscarinic agonist with low tremorogenic activity. In vivo and in vitro studies.
    Engström C, Undén A, Ladinsky H, Consolo S, Bartfai T.
    Psychopharmacology (Berl); 1987 Jan 19; 91(2):161-7. PubMed ID: 3107028
    [Abstract] [Full Text] [Related]

  • 19. Role of specific muscarinic receptor subtypes in cholinergic parasympathomimetic responses, in vivo phosphoinositide hydrolysis, and pilocarpine-induced seizure activity.
    Bymaster FP, Carter PA, Yamada M, Gomeza J, Wess J, Hamilton SE, Nathanson NM, McKinzie DL, Felder CC.
    Eur J Neurosci; 2003 Apr 19; 17(7):1403-10. PubMed ID: 12713643
    [Abstract] [Full Text] [Related]

  • 20. Regulation of muscarinic receptor subtypes and their responsiveness in rat brain following chronic atropine administration.
    Lee W, Wolfe BB.
    Mol Pharmacol; 1989 Nov 19; 36(5):749-57. PubMed ID: 2555673
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.